These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 24523921)

  • 1. Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients.
    Jessen Krut J; Mellberg T; Price RW; Hagberg L; Fuchs D; Rosengren L; Nilsson S; Zetterberg H; Gisslén M
    PLoS One; 2014; 9(2):e88591. PubMed ID: 24523921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF neurofilament protein (NFL) -- a marker of active HIV-related neurodegeneration.
    Abdulle S; Mellgren A; Brew BJ; Cinque P; Hagberg L; Price RW; Rosengren L; Gisslén M
    J Neurol; 2007 Aug; 254(8):1026-32. PubMed ID: 17420923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV.
    Anesten B; Yilmaz A; Hagberg L; Zetterberg H; Nilsson S; Brew BJ; Fuchs D; Price RW; Gisslén M
    Neurol Neuroimmunol Neuroinflamm; 2016 Dec; 3(6):e300. PubMed ID: 27868081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection.
    Hermansson L; Yilmaz A; Axelsson M; Blennow K; Fuchs D; Hagberg L; Lycke J; Zetterberg H; Gisslén M
    J Neuroinflammation; 2019 Jan; 16(1):16. PubMed ID: 30678707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
    Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
    EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy.
    Guha D; Mukerji SS; Chettimada S; Misra V; Lorenz DR; Morgello S; Gabuzda D
    AIDS; 2019 Mar; 33(4):615-625. PubMed ID: 30557159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
    Edén A; Marcotte TD; Heaton RK; Nilsson S; Zetterberg H; Fuchs D; Franklin D; Price RW; Grant I; Letendre SL; Gisslén M
    PLoS One; 2016; 11(6):e0157160. PubMed ID: 27295036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection.
    Anesten B; Zetterberg H; Nilsson S; Brew BJ; Fuchs D; Price RW; Gisslén M; Yilmaz A
    BMC Neurol; 2021 Dec; 21(1):494. PubMed ID: 34937542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
    Jespersen S; Pedersen KK; Anesten B; Zetterberg H; Fuchs D; Gisslén M; Hagberg L; Trøseid M; Nielsen SD
    BMC Infect Dis; 2016 Apr; 16():176. PubMed ID: 27103116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.
    Ulfhammer G; Edén A; Mellgren Å; Fuchs D; Zetterberg H; Hagberg L; Nilsson S; Yilmaz A; Gisslén M
    AIDS; 2018 Sep; 32(15):2171-2178. PubMed ID: 30005007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection.
    Mellgren A; Price RW; Hagberg L; Rosengren L; Brew BJ; Gisslén M
    Neurology; 2007 Oct; 69(15):1536-41. PubMed ID: 17923616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
    Gisslen M; Keating SM; Spudich S; Arechiga V; Stephenson S; Zetterberg H; Di Germanio C; Blennow K; Fuchs D; Hagberg L; Norris PJ; Peterson J; Shacklett BL; Yiannoutsos CT; Price RW
    PLoS One; 2021; 16(5):e0250987. PubMed ID: 33983973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection.
    Ahlgren E; Hagberg L; Fuchs D; Andersson LM; Nilsson S; Zetterberg H; Gisslén M
    PLoS One; 2016; 11(7):e0158973. PubMed ID: 27441551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated cerebrospinal fluid neurofilament light protein concentrations predict the development of AIDS dementia complex.
    Gisslen M; Hagberg L; Brew BJ; Cinque P; Price RW; Rosengren L
    J Infect Dis; 2007 Jun; 195(12):1774-8. PubMed ID: 17492593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection.
    Gisslén M; Heslegrave A; Veleva E; Yilmaz A; Andersson LM; Hagberg L; Spudich S; Fuchs D; Price RW; Zetterberg H
    Neurol Neuroimmunol Neuroinflamm; 2019 Jan; 6(1):e512. PubMed ID: 30568991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.
    Peterson J; Gisslen M; Zetterberg H; Fuchs D; Shacklett BL; Hagberg L; Yiannoutsos CT; Spudich SS; Price RW
    PLoS One; 2014; 9(12):e116081. PubMed ID: 25541953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central and peripheral markers of neurodegeneration and monocyte activation in HIV-associated neurocognitive disorders.
    McGuire JL; Gill AJ; Douglas SD; Kolson DL;
    J Neurovirol; 2015 Aug; 21(4):439-48. PubMed ID: 25776526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients.
    Hagberg L; Fuchs D; Rosengren L; Gisslén M
    J Neuroimmunol; 2000 Jan; 102(1):51-5. PubMed ID: 10626666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection.
    Peluso MJ; Valcour V; Ananworanich J; Sithinamsuwan P; Chalermchai T; Fletcher JL; Lerdlum S; Chomchey N; Slike B; Sailasuta N; Gisslén M; Zetterberg H; Spudich S;
    J Infect Dis; 2015 Dec; 212(11):1759-67. PubMed ID: 25995196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).
    Krut JJ; Price RW; Zetterberg H; Fuchs D; Hagberg L; Yilmaz A; Cinque P; Nilsson S; Gisslén M
    Virulence; 2017 Jul; 8(5):599-604. PubMed ID: 27435879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.